Visibility to necessary patient information enables more efficient collaboration
Success story
Hospital del Mar, Barcelona
One of the most outstanding scientific outputs in Spain, carrying out projects that bring science closer to the health of the people it treats.
Its nine subspecialty tumor boards — breast, colorectal, lung, gynecological, urological, cutaneous, melanoma, endocrine and otorhinolaryngology — provide a multidisciplinary approach to cancer treatment.
Lack of standardization and inefficient tumor board preparation
Each specialist on a tumor board followed his or her own protocol to develop static presentations for weekly meetings without standardization across tumor boards. Presentations were inefficient. Differences between radiological and pathologic recommendations required manual follow up, adding to tumor board preparation for each discipline and taking precious time from collaboration in the weekly conference.
navify® Clinical Hub for Tumor Boards is very helpful … integrating all the information in a fast and dynamic way. It really decreased the effort needed to gather and prepare everything for the tumor board and, most importantly, decreased the errors that one could make in that preparation.
Streamlining tumor board planning
navify Clinical Hub for Tumor Boards was selected to improve tumor board planning and preparation with relevant data consolidated in one place. navify Clinical Hub for Tumor Boards currently facilitates efficient breast cancer tumor board meetings and is rolling out to lung cancer conferences.
Enhanced tumor board preparation and collaboration
navify Clinical Hub for Tumor Boards standardized preparation and presentation processes, so physicians can easily include necessary information, images and findings. Radiology and Pathology can compare interpretations virtually, saving time and showing context to optimize the surgeon’s tumor board preparation. The tumor board meeting is now a smaller part of multidisciplinary team collaboration because specialists have easy access to patient-specific data in navify Clinical Hub for Tumor Boards — anytime, anywhere, through any device with an Internet connection.*
- Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.
- * navify Tumor Board is not mobile-enabled but is accessible in Google Chrome browser.